Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 July 2023

Multidisciplinary Journal Club

  1. D'Haens G, Dubinsky M, Kobayashi T, Irving PM, et al.
    Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.
    N Engl J Med 2023;388:2444-2455.

  1. Khan F, Coyle D, Thavorn K, van Katwyk S, et al.
    Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
    Ann Intern Med 2023.

  2. Provencio M, Nadal E, Gonzalez-Larriba JL, Martinez-Marti A, et al.
    Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.
    N Engl J Med 2023.

  3. He P, Shi L, Li Y, Duan Q, et al.
    The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross-sectional Studies.
    Ann Neurol 2023.

  4. Shingina A, Mukhtar N, Wakim-Fleming J, Alqahtani S, et al.
    Acute Liver Failure Guidelines.
    Am J Gastroenterol 2023;118:1128-1153.

  1. van Barele M, Akdeniz D, Heemskerk-Gerritsen BAM, Andrieu N, et al.
    Contralateral breast cancer risk in irradiated breast cancer patients with a germline-BRCA1/2 pathogenic variant.
    J Natl Cancer Inst 2023.

  2. Adimadhyam S, Lewis JD, Simon AL, Wolfe AE, et al.
    Real-world Evidence Comparing Tofacitinib and Vedolizumab in Anti-TNF-experienced Patients With Ulcerative Colitis.
    Inflamm Bowel Dis 2023.

  3. Tausch C, Daster K, Hayoz S, Matrai Z, et al.
    Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
    Breast Cancer Res Treat 2023.

  4. Martin-Loeches I, Torres A, Nagavci B, Aliberti S, et al.
    ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia.
    Intensive Care Med 2023.

  5. Hwang I, Kim JE, Jeong JH, Ahn JH, et al.
    Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (F
    Breast Cancer Res Treat 2023.

  1. Georgianos PI, Agarwal R.
    Hypertension in chronic kidney disease - treatment standard 2023.
    Nephrol Dial Transplant 2023.

  2. Cho BC, Ahn MJ, Kang JH, Soo RA, et al.
    Lazertinib Versus Gefitinib as First-line Treatment in Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer (NSCLC): Results From LASER301.
    J Clin Oncol 2023.

  3. Clark BZ, Johnson RR, Berg WA, McAuliffe P, et al.
    Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization.
    Breast Cancer Res Treat 2023;200:363-373.

  4. Bruno RR, Wollborn J, Fengler K, Flick M, et al.
    Direct assessment of microcirculation in shock: a randomized-controlled multicenter study.
    Intensive Care Med 2023;49:645-655.

  5. Thompson B, Waterhouse M, English DR, McLeod DS, et al.
    Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial.
    BMJ 2023;381:e075230.

  1. Alfredsson L, Olsson T, Hedstrom AK.
    Inverse association between Mediterranean diet and risk of multiple sclerosis.
    Mult Scler 2023.

  2. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, et al.
    Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.
    Diabetes Care 2023.

  3. Si Lim S, Ford JB, Hermiston ML.
    How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults.
    Blood 2023.

  4. Cooper DS, Mammen JS.
    Symptoms in patients being treated for hypothyroidism: new data in a continuing controversy.
    Thyroid 2023.

  5. Hemar V, Camou F, Roubaud-Baudron C, Ternacle J, et al.
    The Mortality of Infective endocarditis with and without Surgery in the Elderly (MoISE) study.
    Clin Infect Dis 2023.


more..

Privacy Policy